AMETEK (NYSE:AME – Get Free Report) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 7.870-8.070 for the period, compared to the consensus earnings per share estimate of 8.000. The company issued revenue guidance of -. AMETEK also updated its Q1 2026 guidance to 1.850-1.900 EPS.
AMETEK Price Performance
NYSE AME opened at $228.48 on Tuesday. The business’s fifty day moving average is $208.39 and its 200 day moving average is $194.48. AMETEK has a fifty-two week low of $145.02 and a fifty-two week high of $229.03. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.72 and a current ratio of 1.16. The company has a market capitalization of $52.60 billion, a PE ratio of 36.04, a price-to-earnings-growth ratio of 3.05 and a beta of 1.03.
AMETEK Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, December 19th. Investors of record on Friday, December 5th were issued a $0.31 dividend. The ex-dividend date of this dividend was Friday, December 5th. This represents a $1.24 annualized dividend and a yield of 0.5%. AMETEK’s dividend payout ratio is currently 19.56%.
Wall Street Analyst Weigh In
Read Our Latest Report on AMETEK
Insider Buying and Selling
In other AMETEK news, VP Thomas M. Montgomery sold 6,388 shares of AMETEK stock in a transaction on Monday, December 22nd. The shares were sold at an average price of $205.05, for a total value of $1,309,859.40. Following the completion of the transaction, the vice president owned 22,116 shares of the company’s stock, valued at approximately $4,534,885.80. The trade was a 22.41% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Thomas C. Marecic sold 14,310 shares of the company’s stock in a transaction on Monday, December 15th. The stock was sold at an average price of $202.11, for a total transaction of $2,892,194.10. Following the transaction, the insider owned 42,589 shares of the company’s stock, valued at $8,607,662.79. This represents a 25.15% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 137,088 shares of company stock valued at $27,212,340 over the last quarter. 0.57% of the stock is currently owned by company insiders.
Key Stories Impacting AMETEK
Here are the key news stories impacting AMETEK this week:
- Positive Sentiment: Reported record fourth‑quarter and full‑year 2025 results, reinforcing underlying business strength. AMETEK Announces Record Fourth Quarter and Full Year Results
- Positive Sentiment: Completed acquisition of LKC Technologies (adds ophthalmic diagnostic capabilities), expanding AMETEK’s medical/diagnostics exposure and product portfolio. AMETEK Acquires LKC Technologies DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK
- Neutral Sentiment: Pre‑earnings coverage and previews highlight improving process markets and set context for investor expectations ahead of management commentary. Ametek Earnings on Deck as Process Markets Show Signs of Life Ametek Q4 2025 Earnings Preview
- Negative Sentiment: Updated FY‑2026 EPS guidance of $7.87–$8.07 is slightly below the consensus of $8.00, signaling more modest full‑year growth than investors expected.
- Negative Sentiment: Q1‑2026 EPS guidance of $1.85–$1.90 is at/just below the $1.90 consensus; revenue guidance centered around ~$1.9B also met modest expectations — collectively this conservative near‑term outlook is pressuring the stock.
- Negative Sentiment: Giverny Capital trimmed its AMETEK position, citing valuation, which is a small negative signal about investor positioning. Giverny Capital Asset Management Trimmed Ametek (AME) on Valuation
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. Sivia Capital Partners LLC purchased a new stake in shares of AMETEK in the second quarter valued at about $295,000. Hilltop Holdings Inc. acquired a new stake in AMETEK in the 3rd quarter valued at approximately $245,000. Brooklyn Investment Group lifted its stake in AMETEK by 3.2% during the 3rd quarter. Brooklyn Investment Group now owns 1,735 shares of the technology company’s stock worth $326,000 after acquiring an additional 54 shares in the last quarter. B. Riley Wealth Advisors Inc. acquired a new stake in shares of AMETEK during the second quarter worth about $328,000. Finally, Caxton Associates LLP acquired a new stake in AMETEK during the 2nd quarter worth approximately $215,000. 87.43% of the stock is currently owned by institutional investors and hedge funds.
About AMETEK
AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.
The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.
Recommended Stories
- Five stocks we like better than AMETEK
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- End of America Update
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.
